Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 100/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
PRODUCT NAME:LANDIOLOL HCL
CAS NO.: 133242-30-5/144481-98-1
EINECS: 1592732-453-0/1308068-626-2
MOLECULAR WEIGHT: 509.59246/546.05
FORMULA: C25H39N3O8/C25H40CLN3O8
DENSITY:1.201
BOILING POINT:727.5 °C AT 760 MMHG
MELTING POINT:125.4° OC
FLASH POINT:393.8 °C
APPEARANCE:WHITE POWDER
PURITY: ≥98%
PACKAGING:ACCORDING TO CUSTOMER REQUESTS
COUNTRY OF ORIGIN:CHINA
Rapiblyk (landiolol) is a short-term treatment for supraventricular tachycardia including atrial fibrillation and atrial flutter to reduce the ventricular rate. Rapiblyk is a short-acting beta-adrenergic blocker that helps decrease heart rate (negative chronotropic effect) with less lowering of blood pressure. It is given as an intravenous infusion in a monitored setting.
Rapiblyk mechanism of action is a selective beta-1-adrenoreceptor antagonist. By blocking beta-1-receptors that are mainly in the heart, Rapiblyk helps to stop being able to speed up the heart rate, which results in a slower heart rate.
Rapiblyk FDA approval was granted on November 22, 2024, after positive results from clinical trials.
Items | Requirements | Results |
Physical & Chemical | ||
Appearance | White powder | Conform |
Odor | Characteristic | Characteristic |
Particle Size | 98% pass 80mesh | Complies |
Loss on Drying | ≤5.0% | 3.65% |
Ash | ≤5.0% | 1.96% |
Solvent Residue | Meet USP standard | Complies |
Pesticide Residue | Meet USP standard | Complies |
Heavy Metal | ||
Lead (Pb) | ≤2.0ppm | Conform |
(As) | ≤1.0ppm | Conform |
(Cd) | ≤1.0ppm | Conform |
(Hg) | ≤0.1ppm | Conform |
Microorganism | ||
Total Plate Count | ≤1000cfu/g | Conform |
Yeasts and Molds | ≤100cfu/g | Conform |
Saimonella | Negative/25g | Conform |
E.coli | Negative | Conform |
Assay | 99% | 99.5% |